Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Cervical Cancer, March 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 273 articles:
HTML format


 

Single Articles

  1. FU F, Wang T, Wu Z, Feng Y, et al
    Retraction Note: HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Cell Death Dis. 2026;17:232.
    PubMed    


  2. TONOMURA N, Yoshida K, Morita H, Nakai M, et al
    Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study.
    Anticancer Res. 2026;46:1497-1506.
    PubMed    
    Abstract available

  3. GE Z, Zhang C, Zhang Z, Li J, et al
    The causal effect of cytokine cycling levels on the risk of cervical cancer: A bidirectional 2-sample Mendelian randomization study.
    Medicine (Baltimore). 2026;105:e47782.
    PubMed    
    Abstract available

  4. LI W, Liang X, Wu X, Zheng B, et al
    RHBDD1 promotes cervical cancer progression by activating the EGFR/PI3K/AKT signaling pathway.
    Arch Biochem Biophys. 2026 Feb 25:110777. doi: 10.1016/j.abb.2026.110777.
    PubMed    
    Abstract available

  5. BERTOLAZZI M, Genta ML, Lopes A, Fernandes R, et al
    Randomized trial of autologous ovarian graft to preserve ovarian function in young women undergoing pelvic radiotherapy for cervical cancer.
    Eur J Surg Oncol. 2026;52:111496.
    PubMed    
    Abstract available

  6. PECK LC, Petty MC, Walker AR, Huepenbecker SP, et al
    Adherence to 2019 ASCCP Cervical Cancer Screening Guidelines at a Community Health Network.
    J Low Genit Tract Dis. 2026 Feb 27. doi: 10.1097/LGT.0000000000000938.
    PubMed    
    Abstract available

  7. MENG N, Pan J, Wei W, Sun J, et al
    Lymph Node Metastases Prediction in Cervical Cancer Using Time-Dependent Diffusion MRI and Macromolecular Proton Fraction Imaging.
    Radiol Imaging Cancer. 2026;8:e250452.
    PubMed    
    Abstract available

  8. KUSAKABE H, Fukutome T, Suzuki H, Teramoto Y, et al
    Single-organ vasculitis of the uterine cervix mimicking cervical cancer: A case report.
    Case Rep Womens Health. 2026;49:e00787.
    PubMed    
    Abstract available

  9. XIONG J, Qian Y, Wang M, Sun X, et al
    Factors associated with cervical cancer screening participation in Southwest China: a retrospective database-based cross-sectional study.
    Front Med (Lausanne). 2026;13:1740068.
    PubMed    
    Abstract available

  10. SCHULTE-FROHLINDE R, Georges D, Clifford G, Baussano I, et al
    Correction to "Predicting cohort-specific cervical cancer incidence from population-based surveys of human papilloma virus prevalence: a worldwide study".
    Am J Epidemiol. 2026 Feb 27:kwae310. doi: 10.1093.
    PubMed    


  11. KUMAR V, Bharti N, Ranjan R, Pal RR, et al
    CRISPR-Cas9 Gene Editing: Promising Therapeutics for HPV-driven Cervical Cancer.
    Curr Drug Targets. 2026 Feb 23. doi: 10.2174/0113894501437052251204164311.
    PubMed    


  12. ILIA G, Thomopoulos A, Chronas D
    Preserved Menstruation After Chemoradiotherapy in Stage IIIC1 Cervical Cancer: A Unique Case.
    J Clin Med. 2026;15:1550.
    PubMed    
    Abstract available

  13. PRASERTPAKDI S, Suprasert P, Salakphet T, Khunamornpong S, et al
    Cervical Cancer Screening: Histologic Outcomes of HPV-Negative HSIL/ASC-H Cytology in a Tertiary Referral Cohort in Northern Thailand.
    Medicina (Kaunas). 2026;62:371.
    PubMed    
    Abstract available

  14. JULIANTI RA, Putra AD, Fuady A, Nuranna L, et al
    Expression of miR-92a and miR-125b and Their Association with Chemoradiotherapy Response in Locally Advanced Cervical Cancer.
    Int J Mol Sci. 2026;27:1723.
    PubMed    
    Abstract available

  15. REZENDE B, Wolf B, Colman V, Oliveira R, et al
    FIGO 2018 Versus Ontogenetic Staging for Locally Advanced Cervical Cancer: An International Multicenter Cohort Study Comparing the Two Classifications and Their Prognostic Implications.
    Cancers (Basel). 2026;18:689.
    PubMed    
    Abstract available

  16. MULUGETA-GORDON L, Jang M, Dagher C, Nasioudis D, et al
    Advances in the Surgical Management of Cervical Cancer.
    Cancers (Basel). 2026;18:628.
    PubMed    
    Abstract available

  17. YOUSSEF J, El Masri A, Atwi M, Ibrahim E, et al
    Molecular Targets of Cervical Cancer and Its Microenvironment: Advances in Treatment.
    Cancers (Basel). 2026;18:563.
    PubMed    
    Abstract available

  18. KARAMI P, Yahya SI, Roshani S, Parandin F, et al
    Enhanced design of a photonic crystal biosensor for early cervical cancer detection using refractive index variation and neural network classification.
    Sci Rep. 2026 Feb 26. doi: 10.1038/s41598-026-41676.
    PubMed    


  19. ZHAO X, Yang L, Pan J, Zeng Z, et al
    Correction: CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer.
    Sci Rep. 2026;16:7718.
    PubMed    


  20. MITTAL P, Kamalnath J, Charnalia M, Anjana AK, et al
    Point S (sigmoid) doses and correlation with late recto-sigmoid adverse events in patients undergoing image-based brachytherapy for cervical cancer: clinical outcomes.
    Brachytherapy. 2026 Feb 25:S1538-4721(25)00394.
    PubMed    
    Abstract available

  21. BOUGHRIOU M, Zendehdel K, Lotfi F, Gorgati E, et al
    Cervical cancer in foreign-born women living in Italy: A systematic review of population-based studies.
    Cancer Epidemiol. 2026;102:103029.
    PubMed    
    Abstract available

  22. MALIKOVA H, Graffneter K, Kremenova K, Burgetova R, et al
    Pretreatment computed tomography L1 attenuation values: Easy reaching predicting factor for radiation-related bone insufficiency fractures in females treated for advanced cervical cancer (prospective study).
    Womens Health (Lond). 2026;22:17455057261426799.
    PubMed    
    Abstract available

  23. ZHANG Y, Zhang J, Zhong M, Yu L, et al
    A Novel Three-Dimension Printed Individualized Curved-Needle-Based Interstitial Brachytherapy for Re-Irradiation in Uterine Fundus-Involving Recurrent Cervical Cancer: A Case Report.
    Curr Oncol. 2026;33:108.
    PubMed    
    Abstract available

  24. MERCIER NB, Khudina Y, Roberts L, Feely A, et al
    Surgically Treated Cervical Cancer in Manitoba: A Retrospective Study of the Impact of Geography on Care.
    Curr Oncol. 2026;33:70.
    PubMed    
    Abstract available

  25. GU H, Hu B, Jiang Y
    The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons.
    Immunotargets Ther. 2026;15:572970.
    PubMed    
    Abstract available

  26. SUN F, Ge X, Deng L, Wang Y, et al
    Research on a method for early diagnosis and progression prediction of cervical cancer based on imaging omics and molecular omics.
    Front Oncol. 2026;15:1670852.
    PubMed    
    Abstract available

  27. WANG R, Ning L, Li X, Xu Y, et al
    Lactylation-based machine algorithm combined with multi-omics analysis to predict prognosis in cervical cancer.
    Oncol Lett. 2026;31:133.
    PubMed    
    Abstract available

  28. BABATUNDE AN, Aroba OJ, Adeniyi AE, Isiaka SO, et al
    Joint segmentation and classification of cervical cells using U-Net and CNN ensemble for early detection of cervical cancer.
    Cancer Cell Int. 2026 Feb 25. doi: 10.1186/s12935-026-04234.
    PubMed    


  29. DIRIE NI, Hassan MM, Ahmed MM, Hassan J, et al
    Current Cervical Cancer Status in Resource-Limited Somalia: a Systematic Review of Burden, Screening Findings, and Knowledge Gaps.
    J Epidemiol Glob Health. 2026;16:22.
    PubMed    


  30. WU S, Deng Y, Lepp T, Ask LS, et al
    Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study.
    BMJ. 2026;392:e087326.
    PubMed    
    Abstract available

  31. LI J, Chu C, Zhu L, Du Z, et al
    NIR-activated dual-mode oxygen-generating and -delivering nanoplatform for enhanced photodynamic therapy of cervical cancer.
    J Mater Chem B. 2026 Feb 25. doi: 10.1039/d5tb02652.
    PubMed    
    Abstract available

  32. ZHAO X, Zhang X, Xu Y, Huang Y, et al
    Awareness of HPV, HPV vaccine and associated factors among male junior high school students in Zhejiang Province, China.
    Front Public Health. 2026;14:1727798.
    PubMed    
    Abstract available

  33. MAHE L, Cagetti LV, Myxa J, Gonzague-Casabianca L, et al
    Dosimetric comparison between manual and inverse optimization methods in high-dose-rate intracavitary/ interstitial cervical cancer brachytherapy for two treatment planning systems.
    J Contemp Brachytherapy. 2025;17:400-406.
    PubMed    
    Abstract available

  34. KILAR CR, Bajwa HK, Pifer PM, Beriwal S, et al
    Selection of hybrid applicators for adaptive cervical cancer brachytherapy: A practical guide.
    J Contemp Brachytherapy. 2025;17:390-399.
    PubMed    
    Abstract available


  35. Erratum to the article: Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer. Authors: Pittaya Dankulchai, Natthakorn Thanamits
    J Contemp Brachytherapy. 2025;17:421.
    PubMed    
    Abstract available

  36. YIHEYIS MM, Yeheyis MM, Dessie MG, Anagaw YK, et al
    Exploring knowledge, attitudes, and practices on cervical cancer screening and their associated factors among female university students at Debre Markos University, Ethiopia.
    Cancer Treat Res Commun. 2026;47:101147.
    PubMed    
    Abstract available

  37. SULEMAN DB, Folorunsho S
    Cervical cancer research disparities among African immigrant women in the United States: A systematic review.
    Palliat Support Care. 2026;24:e68.
    PubMed    
    Abstract available

  38. FOUCAULT E, Macioce V, Soler M, Pers YM, et al
    Adherence to breast and cervical cancer screening guidelines according to obesity status: a French cross-sectional multicenter survey.
    Prev Med Rep. 2026;63:103405.
    PubMed    
    Abstract available

  39. LI F, Ding S, Chen Z, Chen K, et al
    Potential of margin reduction for cervical cancer radiotherapy in an online adaptive image-guided workflow.
    Phys Imaging Radiat Oncol. 2026;37:100923.
    PubMed    
    Abstract available

  40. DASGUPTA S
    Efficiency of Human Papillomavirus (HPV) Testing in Cervical Cancer Screening and Vaccination: A Review.
    Cureus. 2026;18:e102126.
    PubMed    
    Abstract available

  41. SUN M, Zhou H, Chen J
    Reappraising the clinical value of adjuvant chemoradiotherapy in intermediate-risk cervical cancer: beyond statistical significance.
    Int J Surg. 2026;112:5267-5268.
    PubMed    


  42. CHEN C, Wang S, Liu J, Liao J, et al
    Bone marrow function in cervical cancer patients after concurrent chemoradiotherapy using 99mTc-SC SPECT/CT: A cross-sectional retrospective study.
    Medicine (Baltimore). 2026;105:e47766.
    PubMed    
    Abstract available

  43. JOSHI M, Rajbanshi M, Rana A, Thapa S, et al
    Awareness of cervical cancer, practice of cervical cancer screening and its associated factors among reproductive-aged women in Shankharapur Municipality of Kathmandu district, Nepal: A cross-sectional study.
    Medicine (Baltimore). 2026;105:e47729.
    PubMed    
    Abstract available

  44. ADHIAMBO HF, Thomas K, Coe MM, Oluoch L, et al
    Applying FRAME-IS to characterize provider-led adaptations to a cervical cancer prevention intervention in Kenya.
    Implement Sci Commun. 2026 Feb 24. doi: 10.1186/s43058-026-00883.
    PubMed    
    Abstract available

  45. MOUSAVI-NEJAD S, Rezaei E, Nourizadeh R, Mohammadzadeh Z, et al
    The effect of Fogg model-based virtual education on health literacy and stages of behavior change in cervical cancer screening: study protocol for a randomized controlled trial.
    Trials. 2026 Feb 24. doi: 10.1186/s13063-026-09574.
    PubMed    
    Abstract available

  46. SHEN T, Ma Y, Wu T, Cao Z, et al
    Human papillomavirus16 E7 enhances cell stemness by regulating the APC2/SPIN4/beta-catenin axis in cervical cancer.
    Oncogenesis. 2026 Feb 24. doi: 10.1038/s41389-026-00602.
    PubMed    
    Abstract available

  47. SINGH S, Batra N, Mittal S
    Emerging nanocarrier platforms in cervical cancer therapy: From molecular targeting to precision nanomedicine.
    Nanomedicine. 2026 Feb 21:102913. doi: 10.1016/j.nano.2026.102913.
    PubMed    
    Abstract available

  48. LIU X, Xu T, Wu J, Zhou B, et al
    RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by inducing DNA damage and mitotic catastrophe and enhances cisplatin sensitivity.
    Biochem Pharmacol. 2026;248:117828.
    PubMed    
    Abstract available

  49. JIANG C, Rosenberg PS, Star J, Bandi P, et al
    State-level progress in reducing cervical cancer incidence among US young women between the pre- and post-human papillomavirus vaccination eras.
    J Natl Cancer Inst. 2026 Feb 24:djag051. doi: 10.1093.
    PubMed    
    Abstract available

  50. SINGH N, Raj Jalagam V, Somagattu S, Kunwar S, et al
    Role of Training Paramedical Staff for Cervical Cancer Screening via Human Papillomavirus Self-Sampling in Remote Mountainous Regions: A Pilot Feasibility Study.
    Cureus. 2026;18:e102046.
    PubMed    
    Abstract available

  51. SHARMA V, Gupta N, Leger PD, Ryan WT, et al
    Asymptomatic Cervical Cancer Recurrence Presenting As Gastric Metastasis: A Report of a Rare Case.
    Cureus. 2026;18:e102001.
    PubMed    
    Abstract available

  52. FRANCIS DL
    Maternal Cancer Mortality and Orphanhood: A Neglected Global Health and Equity Challenge.
    Ann Glob Health. 2026;92:18.
    PubMed    
    Abstract available

  53. ZORRILLA CD, Olmo-Lopez CV, Hernandez Garayua AM, Ibarra J, et al
    Associations of HIV RNA Viral Load, CD4 Counts, HPV Detection, and Cytology Support Co-Testing for Cervical Cancer Screening Among Women Living with HIV.
    HIV AIDS (Auckl). 2026;18:553851.
    PubMed    
    Abstract available

  54. XIAMUXI H, Deng X, Ablise M, Yan T, et al
    A novel pyrrolidine-chalcone derivative exhibits synergistic anti-cervical cancer activity by dual-targeting MDM2-p53 axis and ferroptosis pathway.
    Front Pharmacol. 2026;17:1715712.
    PubMed    
    Abstract available

  55. PANDEY P, Hussain A, Khan F
    Editorial: Plant bioactive compounds as modulators of oncogenic signalling pathways in cervical cancer.
    Front Pharmacol. 2026;17:1788689.
    PubMed    


  56. ZIDI S, Yacoubi-Loueslati B, Ben Abdelmoumen Mardassi B, Almawi WY, et al
    A machine learning approach to a nine-SNP immunogenetic score for prognostic stratification in cervical cancer.
    Front Immunol. 2026;17:1759674.
    PubMed    
    Abstract available

  57. LEE SS, Boitano TKL, Hutchcraft ML, Modesitt SC, et al
    #DidYouKnow: Physician engagement online and offline is mission critical to promote accurate and impactful cervical cancer information dissemination.
    Gynecol Oncol Rep. 2026;63:102042.
    PubMed    


  58. TIAN X, Yang H
    Development of bioengineered SPIONs using Carica monoica extract: evaluation of antioxidant and anticancer activity of human cervical cancer cells (SiHa).
    Open Life Sci. 2026;21:20251258.
    PubMed    
    Abstract available

  59. XUE J, Xiao H, Ren X, Yang Q, et al
    Low-molecular-weight metabolites from lactic acid bacteria suppress cervical cancer progression by inhibiting EMT via the Wnt/beta-catenin pathway.
    Open Life Sci. 2026;21:20251264.
    PubMed    
    Abstract available

  60. ABUBAKARI AK, Gross J, Adusei-Poku E
    Understanding Cervical Cancer Screening Intentions Through the Lens of Care-Seeking Behavior: A Cross-Sectional Study Among Islamic Women in Ghana.
    Health Sci Rep. 2026;9:e71827.
    PubMed    
    Abstract available

  61. RIPON RK, Hossain MJ, Prasad NG, Thakkar N, et al
    Cervical Cancer, HPV, and HPV Vaccine Knowledge and Willingness to be Vaccinated Among Adolescent Girls in Dhaka, Bangladesh: A Cross-Sectional Study.
    Health Sci Rep. 2026;9:e71843.
    PubMed    
    Abstract available

  62. SHI R, Hou W, Gao Y, Sun S, et al
    Meta-analysis of risk factors for recurrence in cervical cancer patients following fertility-sparing treatment.
    Front Surg. 2026;12:1625067.
    PubMed    
    Abstract available

  63. BERMUDEZ Y, Miller J, Kenney K, Schlueter D, et al
    Predictors of Breast Cancer Screening Variability Among National Breast and Cervical Cancer Early Detection Program Awardees: Provider Shortages and Nurse Practitioner Autonomy.
    Public Health Rep. 2026 Feb 22:333549261421878. doi: 10.1177/00333549261421878.
    PubMed    
    Abstract available

  64. ALREDHA RDA, Hussein TN, Alzerfi HSR, Haddawi KH, et al
    Evaluation of serum Cytokeratin 5 and p63 as non-invasive biomarkers for the diagnosis and staging of cervical cancer: a case-control study.
    Clin Transl Oncol. 2026 Feb 21. doi: 10.1007/s12094-026-04238.
    PubMed    
    Abstract available

  65. ANDERER S
    At-Home Cervical Cancer Screening Favored by Certain Groups.
    JAMA. 2026 Feb 20. doi: 10.1001/jama.2025.26399.
    PubMed    


  66. ZHAO Y, Sha Z, An T, Wang W, et al
    TMEM130 promoter hypermethylation predicts tumor cell migration in cervical cancer.
    J Mol Histol. 2026;57:83.
    PubMed    
    Abstract available

  67. JIAO Y, He Y, Zhao B, Sha L, et al
    The correlation between the systemic immune-inflammation index and relapse and metastasis in cervical squamous cell carcinoma patients over 50 years and older.
    BMC Immunol. 2026;27:20.
    PubMed    
    Abstract available

  68. FU X, Zhang Q, Wagner AL, Yao Y, et al
    Public Health Impact and Cost-Effectiveness of Routine and Catch-Up Human Papillomavirus Vaccination in Girls and Women in Selected Regions of China: A Model-Based Study.
    Pharmacoeconomics. 2026;44:343-357.
    PubMed    
    Abstract available

  69. OLIVA PJ, Ghosh S, Huang F, Wiebe E, et al
    Towards robust deep learning-based autosegmentation in MRI-planned gynecological brachytherapy: Importance of scalable development and comprehensive evaluation.
    Brachytherapy. 2026;25:361-372.
    PubMed    
    Abstract available

  70. BOGANI G, Sopracordevole F, Corso G, Vizza E, et al
    Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes.
    Tumori. 2026;112:75-82.
    PubMed    
    Abstract available

  71. NISHIOKA K, Sekiyama K, Shiro R, Tsunoda I, et al
    Lack of molecular mimicry between HPV vaccine L1 antigen and human proteins by a computational analysis.
    Int J Clin Oncol. 2026;31:494-503.
    PubMed    
    Abstract available

  72. HUYNH GT, Li A, Nims L, Seiler J, et al
    Intimate Partner Violence and Cervical, Breast, and Colorectal Cancer Screening: Findings from the Washington State Behavioral Risk Factor Surveillance System.
    J Womens Health (Larchmt). 2026;35:413-420.
    PubMed    
    Abstract available

  73. GOYAL A, Davey DD, Souers RJ, Roberson J, et al
    Practice Patterns Regarding Quality Assurance Measures in Gynecologic Cytology: Survey Results of Laboratories Participating in the 2022 College of American Pathologists PAP Education Program.
    Arch Pathol Lab Med. 2025;150:194-201.
    PubMed    
    Abstract available

  74. MILLS AM
    Biomarkers in Cervical Squamous Neoplasia: Diagnostic, Prognostic, and Predictive.
    Arch Pathol Lab Med. 2025;150:e46-e55.
    PubMed    
    Abstract available

  75. THIEU HH, Le TAH, Lao TD
    Meta-analytic and systematic review of the diagnostic value of DNA methylation-based biomarkers in cervical cancer.
    Int J Biol Markers. 2026 Mar 5:3936155261419529. doi: 10.1177/03936155261419529.
    PubMed    
    Abstract available

  76. CAO Y, Peng Y, Shen J
    ANO6 Confers Paclitaxel Resistance by Targeting Ferroptosis in Cervical Cancer.
    Biofactors. 2026;52:e70070.
    PubMed    
    Abstract available

  77. IFEZUOKE TD, Ajah MI, Ajah LO, Ezegwui HU, et al
    Chlamydia trachomatis infection seroprevalence among women with normal and abnormal cervical smears and its implication for Nigerian cervical cancer screening.
    BMC Infect Dis. 2026 Mar 4. doi: 10.1186/s12879-026-12994.
    PubMed    
    Abstract available

  78. REDDY Y, Pai P, Das I, Nayak S, et al
    Topoisomerase inhibitors in cervical cancer: mechanistic insights and therapeutic strategies.
    Mol Med. 2026 Mar 4. doi: 10.1186/s10020-026-01446.
    PubMed    


  79. THASANTHAN L, Hilmi AJ, Rosairo S, Abeysundara HTK, et al
    Impact of treatment duration on cervical cancer outcomes with concomitant chemoradiation.
    Radiography (Lond). 2026;32:103375.
    PubMed    
    Abstract available

  80. YAMAMURA A, Ukita M, Takemura H, Ishibashi T, et al
    Evaluation of neoadjuvant chemotherapy followed by radical hysterectomy in cervical cancer: a single-center study.
    Int J Clin Oncol. 2026 Mar 4. doi: 10.1007/s10147-026-02998.
    PubMed    
    Abstract available

  81. EKER K, Sabour Takanlou M, Sabour Takanlou L, Rostamlou A, et al
    BET inhibition enhances temozolomide sensitivity in cervical cancer cells through ALDH suppression and epigenetic reprogramming.
    Mol Biol Rep. 2026;53:457.
    PubMed    
    Abstract available

  82. SHANG Y, Li K, Liu W, Wang Y, et al
    New Sinomenine Derivative as a Potential Drug for Cervical Cancer via Inducing Ferroptosis.
    Arch Pharm (Weinheim). 2026;359:e70218.
    PubMed    
    Abstract available

  83. ATTIQUE KHAN M, Rauf F, Abbas MJ, Hussain A, et al
    A Novel Network-Level Fused Self-Attention Deep Neural Network for Cervical Cancer Classification from Cervicography Images.
    Technol Cancer Res Treat. 2026;25:15330338261426741.
    PubMed    
    Abstract available

  84. DIEDRICH D, Silva EF, Willig JB, Ruaro TC, et al
    The Privileged Scaffold Quinoline in Derivatives With Anticancer Potential Mediated by Late Apoptosis.
    Anticancer Res. 2026;46:1475-1487.
    PubMed    
    Abstract available

  85. AL-SHIBLI K, Nguyen DT, Mohammed HAL, Sorbye SW, et al
    Genotype-Specific HPV E6/E7 mRNA Triage Improves Risk Stratification and Reduces Referrals in DNA-Positive ASC-US/LSIL: A Real-World Cohort from Nordland, Norway.
    Pathogens. 2026;15:178.
    PubMed    
    Abstract available

  86. STRNADOVA I, Refalo JL, Power R, Basckin C, et al
    'Give People More Time and Take the Time to Explain Things Properly': Cervical Screening Experiences of People With Intellectual Disability.
    J Appl Res Intellect Disabil. 2026;39:e70206.
    PubMed    
    Abstract available

  87. MARTINEZ B, Jennings P, Strik M, Simon K, et al
    Cancer Screening and Barriers to Screening Among Unhoused Individuals in Rhode Island.
    R I Med J (2013). 2026;109:41-47.
    PubMed    
    Abstract available

  88. LI L, Wang Y, Liu L, Lou Y, et al
    Miniaturized Single-Step Duplex CRISPR Diagnostic Platform for At-Home Molecular Testing of HPV16 and HPV18.
    ACS Sens. 2026;11:1117-1128.
    PubMed    
    Abstract available

  89. RINDAL DB, Asche S, Kharbanda E, Michalowicz B, et al
    Increasing HPV vaccine promotion by dental providers: A clinical trial protocol.
    Contemp Clin Trials. 2026;162:108222.
    PubMed    
    Abstract available

  90. GODDARD Q, Coward S, Seow CH, Bertazzon S, et al
    Association of Geography With Screening and Development of Cervical Neoplasia in Those With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 Nov 20:izaf249. doi: 10.1093.
    PubMed    
    Abstract available

  91. KIM A, Kim J, Kwak W, Mo K, et al
    Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer.
    Int J Oncol. 2026;68:57.
    PubMed    
    Abstract available

  92. ZHOU J, Ye W, Ranarisoa SN, Tian L, et al
    Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis.
    Front Immunol. 2026;17:1775409.
    PubMed    
    Abstract available

  93. JI LY, Wang X, Jiao RX, Yang J, et al
    Application of Cytokines in Cervical Secretion for High-grade Squamous Intraepithelial Lesion Caused by High-risk Human Papillomavirus Infection.
    Biomed Environ Sci. 2026;39:215-222.
    PubMed    
    Abstract available

  94. WILLIAMS DM, Reilly S, Lord T, Ayers K, et al
    "Give me the sense that I matter:" Queer women's recommendations for an ideal cervical cancer screening exam and pathways to screening equity.
    Womens Health (Lond). 2026;22:17455057261428108.
    PubMed    
    Abstract available

  95. VAN KEER S, van den Helder R, Teblick L, De Smet A, et al
    Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.
    Commun Med (Lond). 2026 Mar 12. doi: 10.1038/s43856-026-01512.
    PubMed    
    Abstract available

  96. LIU X, Vidrine DJ, Sutton SK, Wetter DW, et al
    Cost-Effectiveness of Smoking Cessation Among Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer.
    JAMA Netw Open. 2026;9:e261543.
    PubMed    
    Abstract available

  97. ZHANG L, Quan R, Huang H, Wu M, et al
    Boronophenylalanine-Mediated Boron Neutron Capture Therapy Confers Selective Killing of Cervical Cancer by Exploiting DNA Repair Deficiency.
    Cancer Biother Radiopharm. 2026 Mar 12:10849785261426657.
    PubMed    
    Abstract available

  98. TAWE L
    Mapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control.
    Health Sci Rep. 2026;9:e72038.
    PubMed    
    Abstract available

  99. CHENG Y, Wang J, Wang L, Yan D, et al
    Systemic immune-inflammatory index for the prediction of the survival in patients with cervical cancer: A meta-analysis.
    iScience. 2026;29:114862.
    PubMed    
    Abstract available

  100. LIANG H, Li Q, Liao Y, Huang H, et al
    Rosa roxburghii Tratt fruit polysaccharides inhibit proliferation and induce apoptosis in human cervical cancer cell line.
    Transl Cancer Res. 2026;15:121.
    PubMed    
    Abstract available

  101. KIVUTI-BITOK LW, Mugo CW, Mituki D, Marete C, et al
    The effect of school-based educational session on knowledge, attitudes, and beliefs of cervical cancer among adolescents in mixed day high schools in Embu County: a quasi-experimental study.
    BMC Public Health. 2026 Mar 11. doi: 10.1186/s12889-026-26675.
    PubMed    
    Abstract available

  102. TANG X, Peng X, Zhang W, Li Z, et al
    Ultrasensitive Electrochemiluminescence Nanoprobe for Early Screening and Early Diagnosis of Cervical Cancer.
    Anal Chem. 2026 Mar 11. doi: 10.1021/acs.analchem.5c08162.
    PubMed    
    Abstract available

  103. CLAIRE LIN CC, Tai CC, Hung P, Tung YC, et al
    Corrigendum to "Community mobile health clinics' availability is associated with cervical cancer screening in rural and urban areas: A national cohort study in Taiwan" [Taiwan J Obstet Gynecol 64 (2025) 1024-1029].
    Taiwan J Obstet Gynecol. 2026;65:399.
    PubMed    


  104. ZHENG J
    Comment on "Recent advances in cervical cancer treatment: Innovations from early-stage to advanced disease".
    Taiwan J Obstet Gynecol. 2026;65:393.
    PubMed    


  105. WENG CS, Chen RC, Chen HJ, Tsay JY, et al
    Genotype-specific prevalence of high-risk human papillomavirus among cytologically normal women in Taiwan.
    Taiwan J Obstet Gynecol. 2026;65:292-298.
    PubMed    
    Abstract available

  106. WANG CC, Liu SH, Wu MH, Chen JR, et al
    Increased risk of ischemic stroke in cervical cancer patients received radiotherapy: A nationwide population-based study.
    Taiwan J Obstet Gynecol. 2026;65:247-255.
    PubMed    
    Abstract available

  107. RYU SY, Nam BH, Kim MH, Jang WI, et al
    A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study.
    ESMO Open. 2026;11:106102.
    PubMed    
    Abstract available

  108. LIN S, Ouyang Y, Gu H, Chen K, et al
    Toward fully automated pre-implantation planning for cervical cancer brachytherapy: a template-guided multi-criteria optimization framework for catheter placement and dose distribution.
    Phys Med Biol. 2026 Mar 11. doi: 10.1088/1361-6560.
    PubMed    
    Abstract available

  109. HUA Y, Li Y, Qin H, Huo M, et al
    Association Between Folate Status and Risk of Cervical Cancer: A Systematic Review, Dose-Response Meta-analysis, and Mendelian Randomization Study.
    Nutr Rev. 2026 Mar 11:nuag016. doi: 10.1093.
    PubMed    
    Abstract available

  110. CAKIR Z, Gok Ugur H
    The Effect of Motivational Interviewing Based on the COM-B Model on Women's Cervical Cancer Health Beliefs and Participation in Screening: A Single-Blind Randomized Controlled Trial.
    Cancer Nurs. 2026 Mar 10. doi: 10.1097/NCC.0000000000001553.
    PubMed    
    Abstract available

  111. GOTTSCHLICH A, Smith LW, Hong Q, Dabee S, et al
    HPV, Cytology, and Cotest Cervical Cancer Screening and the Risk of Precancer.
    JAMA Netw Open. 2026;9:e261304.
    PubMed    
    Abstract available

  112. HUANG J, Li X, Zhuang Y, Zhang Z, et al
    Nomogram Prediction Model and Prognostic Comparison of Cervical Clear Cell Carcinoma and Cervical Endometrioid Adenocarcinoma: A SEER Database Study.
    Cancer Med. 2026;15:e71699.
    PubMed    
    Abstract available

  113. LI G, Lu Z, Yin F, Lu H, et al
    High-risk HPV and bacterial STIs in a primary screening population in rural Hainan, China: prevalence, co-infection, and association with cervical abnormalities.
    Front Public Health. 2026;14:1773020.
    PubMed    
    Abstract available

  114. GONZALEZ GMN, Inam ME, Msadabwe S, Lee KL, et al
    Social Determinants of Health Impact Cervical Cancer Stage at Presentation among Women in Zambia.
    Res Sq [Preprint]. 2026 Feb 23:rs.3.rs-8522732. doi: 10.21203/rs.3.rs-8522732.
    PubMed    
    Abstract available

  115. BODHARE T, Bele S, V S, Sheela Kumari K S, et al
    An Intervention Study Assessing the Effects of a Breast and Cervical Cancer Health Education Program on Knowledge, Attitudes, and Practices Among Adolescent Female Students in Madurai, South India.
    Cureus. 2026;18:e103131.
    PubMed    
    Abstract available

  116. MAYUMI WADA C, Ferrari G, Silveira da Silva L, Pitton M, et al
    Intrauterine devices incorporating nanocarriers for targeted cervical cancer therapy.
    Nanomedicine (Lond). 2026 Mar 11:1-13. doi: 10.1080/17435889.2026.2641148.
    PubMed    
    Abstract available

  117. TRYBUS W, Trybus E, Krol T
    Alizarin induces a multidirectional mechanism of anti-cancer action in cervical cancer and prostate cancer cells.
    Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43011.
    PubMed    
    Abstract available

  118. ALSULAYS BB, Anwer MK, Hatata MN, Raish M, et al
    Development of beta-CD metal organic frameworks loaded with olaparib: a novel approach for the treatment of cervical cancer.
    Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43779.
    PubMed    


  119. SUROV A, Hohn AK, Hinnerichs M, Meyer HJ, et al
    Associations Between Body Composition and Intratumoural Immune Cells in Patients With Uterine Cervical Cancer.
    J Cachexia Sarcopenia Muscle. 2026;17:e70241.
    PubMed    
    Abstract available

  120. IWAHASHI N, Noguchi T, Sakai K, Yahata T, et al
    Comprehensive circulating tumor DNA mutation profiling via CAPP-Seq liquid biopsy for cervical cancer.
    Int J Clin Oncol. 2026 Mar 10. doi: 10.1007/s10147-026-03006.
    PubMed    
    Abstract available

  121. ZHANG X, Yin Y, Yang T, Cong Y, et al
    HALP outperforms systemic inflammatory biomarkers for prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Biomol Biomed. 2026 Mar 10. doi: 10.17305/bb.2026.13993.
    PubMed    
    Abstract available

  122. TUSAR MTT, Ara R, Farazi R, Roy CR, et al
    Complete genome sequence of human papillomavirus type 45 identified from a cervical cancer patient in Bangladesh.
    Microbiol Resour Announc. 2026 Mar 10:e0138225. doi: 10.1128/mra.01382.
    PubMed    
    Abstract available

  123. XIAO G, Quan K, Zeng M, Ye Y, et al
    Region-specific Multi-Omics Modeling for Predicting Acute Radiation-Induced Proctitis in Cervical Cancer Radiotherapy: A Retrospective Analysis.
    Technol Cancer Res Treat. 2026;25:15330338261424144.
    PubMed    
    Abstract available

  124. WU H, Yu Y, Wang W, Xu Q, et al
    SMC4/SMAD3/NF-kappaB axis drives cervical cancer progression and radioresistance via DNA damage repair and immune modulation.
    J Transl Med. 2026 Mar 9. doi: 10.1186/s12967-026-07979.
    PubMed    
    Abstract available

  125. ZOU Z, Huang L, Yin K, Li Y, et al
    Effect of immune-related lncRNA BZRAP1-AS1/miR-541-3p and its molecular mechanism in cervical cancer.
    World J Surg Oncol. 2026 Mar 9. doi: 10.1186/s12957-026-04270.
    PubMed    


  126. HU D, Zhao Y, Han M, Qian W, et al
    Analysis of factors associated with cervical cancer and precancerous lesions.
    Sci Rep. 2026 Mar 9. doi: 10.1038/s41598-025-32215.
    PubMed    
    Abstract available

  127. KONG W, Liu P, Zhang J, Liu Q, et al
    Chemoradiotherapy facilitates siglec-10(+)/siglec-9(+) macrophage-mediated impairment of CD24(+)/MUC16(+) tumor cell elimination and enhances PD-L2 dependent immunosuppression in cervical cancer.
    Cancer Immunol Immunother. 2026;75:97.
    PubMed    
    Abstract available

  128. PAIVA SANTOS J, Prata R, Serrado MA, Cunha TM, et al
    Evaluating lymph node metastases in cervical cancer: the added value of T2/DWI MRI fusion compared to standard MRI alone and 18 F-FDG PET/CT.
    Abdom Radiol (NY). 2026 Mar 9. doi: 10.1007/s00261-026-05415.
    PubMed    
    Abstract available

  129. GUO Y, Li S, Liu T, Chang X, et al
    Gene Mutations and Related Molecular Events in Distant Metastasis of Cervical Cancer: A Review.
    Int J Med Sci. 2026;23:1015-1032.
    PubMed    
    Abstract available

  130. PAN G, Wang W, Sun Z, Chu R, et al
    High-Risk Clinical Characteristics and Risk Model for Unexpected Cervical Cancer Diagnosed After Surgery in Patients with LSIL/HSIL Biopsy.
    Int J Womens Health. 2026;18:584455.
    PubMed    
    Abstract available

  131. CUI Y, Li Y, Na J, Lu J, et al
    Investigating the causal association between plasma lipids and the risk of squamous cervical cancer: A two-sample mendelian randomization study.
    J Med Biochem. 2025;44:1843-1849.
    PubMed    
    Abstract available

  132. SANCHEZ DIAZ E, Levin G, Fernandes A, Fletcher A, et al
    Clinical evidence on a Coriolus versicolor-based vaginal gel for HPV-related cervical disease: a narrative review.
    Chin Clin Oncol. 2026;15:9.
    PubMed    
    Abstract available

  133. WANG J, Zhang Y, Wang H, Zhang J, et al
    Cystathionine-gamma-Lyase/Hydrogen Sulfide Axis Plays a Crucial Role in Promoting the Progression of Cervical Cancer.
    J Biochem Mol Toxicol. 2026;40:e70765.
    PubMed    
    Abstract available

  134. KONGWATTANAKUL S, Petroch P, Nimjaroen K, Bawornpatarapakorn S, et al
    The effectiveness of a 3-dimensional printed vaginal dilator in mitigating radiation-induced vaginal stenosis for patients with cervical cancer.
    J Gynecol Oncol. 2026 Feb 24. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  135. ZHANG G, Zhang X, Li H, Du X, et al
    Multi-omic and immune landscapes of HPV-negative versus HPV-positive cervical cancer reveal implications for immunotherapy.
    Eur J Surg Oncol. 2026;52:111425.
    PubMed    
    Abstract available

  136. SUSHMA N, C R TP, Y S N, Kaginelli S, et al
    Analysis of In-Vivo Dose Measurement of Urethra Using Array MOSFET Detectors and TPS-Calculated Dose in High-Dose-Rate Interstitial Brachytherapy in Gynaecological Malignancies.
    Asian Pac J Cancer Prev. 2026;27:1091-1098.
    PubMed    
    Abstract available

  137. SRIVASTAVA H, Raghuvanshi S, Bhalla S, Raghuvanshi S, et al
    PIK3CA Polymorphisms in Cervical Cancer: Differential Impact of rs6443624 and rs141178472.
    Asian Pac J Cancer Prev. 2026;27:1061-1068.
    PubMed    
    Abstract available

  138. FATIHA RA, Ngabdi CK, Azizah JS, Putri BSN, et al
    Disruption of EMT Signaling and Migration by Moringa oleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2026;27:981-988.
    PubMed    
    Abstract available

  139. MOSAVI JARRAHI A, Rajaie S, Azari S, Karimi F, et al
    Standardizing Cost-Effectiveness Evidence for Cancer Prevention: A Case Study Analysis of HPV Vaccination.
    Asian Pac J Cancer Prev. 2026;27:789-792.
    PubMed    
    Abstract available

  140. ZHENG L, Zhao G, Zheng L, Zou Y, et al
    Insights Into Highly Associated Co-Factors on HPV-Related Cervical Cancer.
    Rev Med Virol. 2026;36:e70131.
    PubMed    
    Abstract available


  141. Prophylactic para-aortic irradiation vs pelvic radiotherapy in pelvic node-positive carcinoma cervix in the setting of concurrent chemoradiation: a phase II open-label multi centric randomized controlled trial (PRO-PARA).
    Trials. 2026;27:195.
    PubMed    
    Abstract available

  142. JIA M, Zeng S, Zou J, Chen H, et al
    Predicting Risk of Lymph Node Metastasis in Neuroendocrine Carcinoma of Cervix: A Validated Nomogram Incorporating Neuroendocrine Markers and Clinical Parameters.
    Cancer Med. 2026;15:e71686.
    PubMed    
    Abstract available

  143. MATOBA Y, Oomori Y, Nishibuchi I, Uegami S, et al
    Reirradiation for Recurrent Cervical Cancer Within the Previous Radiation Field Using a Bioabsorbable Spacer: A Case Report.
    J Obstet Gynaecol Res. 2026;52:e70225.
    PubMed    
    Abstract available

  144. CHEN X, Zheng X, Yang Z, Sui F, et al
    Clinicopathologic characteristics and survival outcomes of patients with high-grade neuroendocrine cervical cancer.
    Medicine (Baltimore). 2026;105:e47961.
    PubMed    
    Abstract available

  145. LI Y, Zhang W, Tang L, Zhu Y, et al
    Core targets of bisphenol A in cervical cancer revealed by network toxicology and molecular docking.
    Medicine (Baltimore). 2026;105:e47993.
    PubMed    
    Abstract available

  146. LI C, Zhao H, Wang J, Liu C, et al
    A tumor-resident bacterium promotes cervical cancer progression through lysoPC-mediated c-Jun/c-Fos activation.
    Cell Rep. 2026;45:117079.
    PubMed    
    Abstract available

  147. ZHANG J, Zhang Y, Zhang J
    BATF Drives Cervical Cancer Progression and Immune Evasion by Regulating the STAT1-PD-L1 Axis.
    Iran J Immunol. 2026;23.
    PubMed    
    Abstract available

  148. POY M, Jacquot K, Gross S, Lepiller Q, et al
    [Development and distribution of an inter-laboratory comparison test for HPV testing].
    Virologie (Montrouge). 2026;30:63-69.
    PubMed    
    Abstract available

  149. CHARPENTIER C, Brousseau J, Jary A, Ferre VM, et al
    [Cervical cancer screening: what role for methylation tests?].
    Virologie (Montrouge). 2026;30:19-32.
    PubMed    
    Abstract available

  150. DOGHMAN I, Malassigne V, Roucaute L, Azais H, et al
    [Advances in screening and follow-up of HPV-related cervical cancer].
    Virologie (Montrouge). 2026;30:7-18.
    PubMed    
    Abstract available

  151. ZHAO J, Wang L, Shao N, Qu Y, et al
    RRM2/GCH1 signaling decreased cisplatin sensitivity in cervical cancer by modulating the ferroptosis process.
    Histol Histopathol. 2026 Mar 6:25056. doi: 10.14670.
    PubMed    
    Abstract available


  152. Corrigendum to "Prevalence of Human Papillomavirus Subtypes and Related Cytology in Estonian Cervical Cancer Screening Population in 2021".
    Cancer Control. 2026;33:10732748261431083.
    PubMed    


  153. SVINTSITSKY V, Yegorov M, Stakhovsky E, Vitruk Y, et al
    NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES.
    Exp Oncol. 2026;47:467-477.
    PubMed    
    Abstract available

  154. FASZHOLZ AM, Lozano V, Garda J
    Structure, utilization, and screening adherence of a student-run women's health clinic for uninsured Spanish-speaking women: A descriptive analysis.
    Womens Health (Lond). 2026;22:17455057261424823.
    PubMed    
    Abstract available

  155. KIRUTHIGA N, Krishnan S, Arulsamy S, Natarajan A, et al
    Design and Synthesis of Piperidine Hydroxamate Scaffolds as Novel HDAC Inhibitors with Apoptotic Potential in Human Cervical Cancer Cells.
    Med Chem. 2026 Mar 2. doi: 10.2174/0115734064378681251128061500.
    PubMed    
    Abstract available

  156. SHADANG M, Arumugam A, Singh DK, Keshari P, et al
    The R2TP complex stabilises E7 to drive human papillomavirus-mediated pathogenesis in cellular models of cervical cancer.
    Virol J. 2026;23:66.
    PubMed    
    Abstract available

  157. ZHU Y, Liu K, Yang Z, Peng Z, et al
    Machine-learning with multiomics for radiotherapy-induced acute rectal toxicities and survival outcome in patients with cervical cancer.
    Radiat Oncol. 2026 Mar 5. doi: 10.1186/s13014-026-02814.
    PubMed    


  158. BENCHEIKH S, Lemriss H, Souiri A, Akachar J, et al
    Human papillomavirus-encoded microRNAs: key regulators in cervical cancer development.
    RNA Biol. 2026;23:1-14.
    PubMed    
    Abstract available

  159. NGHIEM VTH, Smith S, Shi J, McBrayer A, et al
    Acceptability and Feasibility of Home-Based Human Papillomavirus Self-Testing as Primary Screening for Cervical Cancer Detection in the State of Alabama.
    J Community Health. 2026 Mar 6. doi: 10.1007/s10900-026-01554.
    PubMed    
    Abstract available

  160. ISLAM O, Assaduzzaman M, Akter S, Fahad N, et al
    Enhanced cervical cancer diagnosis using a novel Bayesian fusion ensemble method with explainable AI.
    Sci Rep. 2026 Mar 5. doi: 10.1038/s41598-026-35334.
    PubMed    


  161. MIAO Z, Yang XL, Zhu JW, Zhou YC, et al
    The differences of pelvic lymph node metastasis between squamous cell carcinoma and adenocarcinoma in early-stage cervical cancer patients undergoing radical surgery and adjuvant radiotherapy: a large cohort study.
    Ther Adv Med Oncol. 2026;18:17588359261425694.
    PubMed    
    Abstract available

  162. KYEI-ARTHUR F, Agyekum MW, Afrifa-Anane GF, Alhassan N, et al
    Cervical Cancer Screening Prevalence and Predictors Among Women Aged 25-49 Years in Ghana: A Cross-Sectional Study.
    Health Sci Rep. 2026;9:e71971.
    PubMed    
    Abstract available

  163. ANSARI SN, Kunwar R, Vaidya SA
    Immunohistochemical Expression of P16 in Cervical Lesions: An Observational Study.
    JNMA J Nepal Med Assoc. 2025;63:823-827.
    PubMed    
    Abstract available

  164. ULMER KK, Sargent MD, Cina KR, Vinson AH, et al
    Native American Women's Willingness to Screen for Both Cervical and Colorectal Cancer at Home.
    Cancer Med. 2026;15:e71654.
    PubMed    
    Abstract available

  165. BERHANU W, Yigremachew S, Hanson C, Avermark H, et al
    A missed opportunity: faith leaders and the HPV vaccination effort in Addis Ababa, Ethiopia.
    Glob Health Action. 2026;19:2635822.
    PubMed    
    Abstract available

  166. EL-MOGASSABI A, Baiu HS, Hassan NO, Salem EM, et al
    Translation, adaptation and validation of the AWACAN tool for breast and cervical cancer awareness among Arabic-speaking women: a study from Libya.
    Ecancermedicalscience. 2025;19:2047.
    PubMed    
    Abstract available

  167. PUENTE-VALLEJO R, Garcia-Gutierrez A, Jara-Jimenez S, Mosquera-Ruiz MN, et al
    Impact of treatment delay on survival in women diagnosed with cervical cancer in Quito, Ecuador: a retrospective cohort study.
    Ecancermedicalscience. 2025;19:2039.
    PubMed    
    Abstract available

  168. DAS NEVES MAB, Galvao ND, de Lima FCDS, Oliveria JFP, et al
    Factors associated with advanced diagnosis of cervical cancer: a hospital-based retrospective study in a state of the Brazilian Legal Amazon.
    Ecancermedicalscience. 2025;19:2045.
    PubMed    
    Abstract available

  169. MATHOBELA MN, Chuang TW, Chen PC, Motsa MPS, et al
    Prevalence and factors associated with urinary schistosomiasis in women attending cervical cancer screening in Sithobela, Eswatini: A facility-based cross-sectional study.
    Helminthologia. 2025;62:296-303.
    PubMed    
    Abstract available

  170. KIM JH, Shim SH, Min KJ, Lee JK, et al
    Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk HPV testing in cervical cancer screening.
    Obstet Gynecol Sci. 2026 Mar 4. doi: 10.5468/ogs.26066.
    PubMed    
    Abstract available

  171. MURAHWA AT, Dzobo M, Mahenge A, Rantshabeng P, et al
    The Burden of HPV35 in African Cervical Pathologies: Prevalence, Contributing Factors, and Vaccine Prospects.
    Rev Med Virol. 2026;36:e70129.
    PubMed    
    Abstract available

  172. MA X, Xu Z, Chen Y, Jiang F, et al
    KIF20A promotes cervical cancer progression by interacting with CLIP1.
    Sci Rep. 2026 Mar 3. doi: 10.1038/s41598-026-42883.
    PubMed    


  173. ZHANG H, Luo X, Jiang J, Zhang C, et al
    The clinical application value of dynamic monitoring of HPV ctDNA in concurrent chemoradiotherapy for locally advanced cervical cancer.
    NPJ Precis Oncol. 2026 Mar 3. doi: 10.1038/s41698-026-01348.
    PubMed    
    Abstract available

  174. KOVACEVIC IN, Jovanovic A, Ristic J, Milic N, et al
    Effect of Organized Cervical Cancer Screening Programs on Incidence and Mortality: A Systematic Review and Meta-analysis.
    J Prev (2022). 2026 Mar 4. doi: 10.1007/s10935-026-00908.
    PubMed    
    Abstract available

  175. ZHANG Y, Gao Y, Guan X, Wang E, et al
    LILRB4 shapes an immunosuppressive microenvironment to drive cervical cancer progression through tumor-infiltrating myeloid cell expansion and CD8(+) T-cell suppression.
    Cell Mol Life Sci. 2026;83:146.
    PubMed    
    Abstract available

  176. GAO H, Gao Q, Xue L, Lin H, et al
    Risk Stratification for Underlying Cervical Intraepithelial Neoplasia Grade (CIN)3+ in Reproductive-Age Women With Biopsy-Confirmed CIN2: Implications for Fertility-Preserving Management.
    Cancer Control. 2026;33:10732748261427836.
    PubMed    
    Abstract available

  177. REN W, Cui Z, Wu S, Shen F, et al
    A Clinical-DKI Fusion Model for Objective Pretreatment Prediction of Parametrial Invasion in Cervical Cancer.
    Acad Radiol. 2026 Mar 2:S1076-6332(26)00108-X. doi: 10.1016/j.acra.2026.
    PubMed    
    Abstract available

  178. LIN J, Wu Q, Liu B, He H, et al
    Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial.
    J Gynecol Oncol. 2026 Feb 9. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  179. SSETAALA A, Muwonge I, Namulwa D, Kyakuwa N, et al
    Cervical Cancer Screening in Uganda: Determinants of Past Screening and Post-Education Uptake; A Cross-Sectional Survey.
    Cancer Control. 2026;33:10732748261427062.
    PubMed    
    Abstract available

  180. JIANG L, Ma S, Du Q, Lv J, et al
    Prognostic value of Node-RADS scoring in stage IIICr cervical cancer: development and validation of novel nomograms.
    Insights Imaging. 2026;17:64.
    PubMed    
    Abstract available

  181. PENG Y, Wang L, Jin F, Su Z, et al
    Application of Manual Lymph Drainage Combined With Complex Decongestive Therapy in Lower Limb Lymphedema After Cervical Cancer Surgery and Its Impact on Quality of Life.
    J Obstet Gynaecol Res. 2026;52:e70217.
    PubMed    
    Abstract available

  182. YANG T, Tang M, Xu L, Jiang L, et al
    A tailored phosphorothioate coordinator enables CRISPR/Cas in-situ amplification.
    Nucleic Acids Res. 2026;54:gkag187.
    PubMed    
    Abstract available

  183. BI Y, Ye Y, Wu X, Cao H, et al
    Mechanism of isoleucyl-tRNA synthetase 2 regulating proliferation and apoptosis of cervical cancer cells.
    Sci Rep. 2026 Mar 2. doi: 10.1038/s41598-026-41218.
    PubMed    


  184. HASSINE A, Tisler A, Martel M, Bardou M, et al
    Risk of cervical cancer and high-grade lesions in vulnerable women a systematic review and meta-analysis.
    Nat Commun. 2026 Mar 2. doi: 10.1038/s41467-026-70050.
    PubMed    
    Abstract available

  185. ZI XJ, Li YL, Chu ZY
    Mechanisms of bisphenols-induced cervical cancer: A multidimensional bioinformatics analysis.
    Reprod Toxicol. 2026;141:109209.
    PubMed    
    Abstract available

  186. MASSAD LS
    Incremental Progress in the Cervical Cancer Screening Revolution.
    J Clin Oncol. 2026 Mar 2:JCO2503021. doi: 10.1200/JCO-25-03021.
    PubMed    


  187. ISAACSON S, Spees LP, Hudgens MG, Pence BW, et al
    Racial differences in expected versus actual costs of cervical cancer screening among low-income, under-screened women in North Carolina.
    Cancer Epidemiol Biomarkers Prev. 2026 Mar 2. doi: 10.1158/1055-9965.EPI-25-0885
    PubMed    
    Abstract available

  188. ACHARYA GC, Das S, Jasuja A, Debata I, et al
    Perception, Practices, and Barriers to Cervical Cancer Screening Among Women in Rural and Urban Slums of Eastern India: A Community-Based Cross-Sectional Study.
    Cureus. 2026;18:e102449.
    PubMed    
    Abstract available

  189. ZHOU G, Chen W, Dong X, Guo Q, et al
    Nocardia rubra cell wall skeleton-induced MARCO expression: implications for improved phagocytosis and cytokine secretion in tumor-associated macrophages.
    Front Immunol. 2026;17:1611476.
    PubMed    
    Abstract available

  190. ZELINI P, Zavaglio F, Dominioni M, Valsecchi M, et al
    Detection of human papillomavirus (HPV)-specific T cell response in women with low-grade cervical intraepithelial lesion and HPV vaccinated subjects.
    Front Immunol. 2026;16:1733404.
    PubMed    
    Abstract available

  191. KOTIAN N, Reddy Y, Pai P, Sundara BK, et al
    A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review.
    Cancer Med. 2026;15:e71482.
    PubMed    
    Abstract available

  192. ALI AA, McCrudden CM, McCaffrey J, McBride JW, et al
    DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.
    Nanomedicine. 2026 Feb 27:102923. doi: 10.1016/j.nano.2026.102923.
    PubMed    
    Abstract available

  193. MENGISTIE MB, Ayalew WL, Mengistie SK, Gebeyehu AS, et al
    Prevalence of cervical cancer and its associated factors among women living with HIV attending public referral hospitals in Amhara Region, Ethiopia, 2025, a cross-sectional study.
    BMC Infect Dis. 2026 Feb 28. doi: 10.1186/s12879-026-12976.
    PubMed    


  194. FREIJOMIL-VAZQUEZ C, Gastaldo D
    The Intersecting Effects of Biomedicine and Patriarchy on the Social Lives of Women Undergoing Cervical Cancer Prevention.
    Semin Oncol Nurs. 2026 Feb 27:152173. doi: 10.1016/j.soncn.2026.152173.
    PubMed    
    Abstract available

  195. WILLIAMS HR, Kelly D
    Prevention and Diagnosis of Cervical Cancers in the UK and Europe: What Have We Learned in the Last 10 Years and What Is Next?
    Br J Hosp Med (Lond). 2026;87:50727.
    PubMed    
    Abstract available

  196. MASUMOTO S, Tanaka M, Yamamoto K, Hori Y, et al
    HPV18-positive Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Treated With Immunotherapy: A Case Report.
    Anticancer Res. 2026;46:1733-1739.
    PubMed    
    Abstract available

  197. VEGA C, Leon R, Medina N, Fabelo H, et al
    Design and Characterization of a Hyperspectral Colposcope Based on Dual-LCTF VNIR Narrow-Band Illumination.
    Sensors (Basel). 2026;26:1255.
    PubMed    
    Abstract available

  198. AZIZAH JS, Ngabdi CK, Fatiha RA, To SW, et al
    Physicochemical characterization and anticancer potential of Ficus deltoidea-silver nanoparticles (FD-AgNPs) on HeLa cells: Evidence from apoptosis and proliferation assays.
    Biochem Biophys Res Commun. 2026;808:153407.
    PubMed    
    Abstract available

  199. ZHANG J, Wang H, Liu Y, Li Z, et al
    HPV testing with 16/18 genotyping for risk stratification among women with normal cytology: a multicenter prospective cohort study from China.
    J Clin Microbiol. 2026 Feb 19:e0128925. doi: 10.1128/jcm.01289.
    PubMed    
    Abstract available

  200. NITTA N, Sugiyama Y, Sugimura T, Ito T, et al
    Clinical-grade autonomous cytopathology through whole-slide edge tomography.
    Nature. 2026;651:472-481.
    PubMed    
    Abstract available

  201. JUNIOR DST
    Incorporation of HPV-DNA molecular test into the Brazilian healthcare system.
    J Cancer Policy. 2026;47:100713.
    PubMed    
    Abstract available

  202. XUE L, Hao S, Sun H, Du L, et al
    Spatial clustering of gynecological cancers in China: A countrywide migration-adjusted analysis at the district level.
    Cancer Epidemiol. 2026;101:103023.
    PubMed    
    Abstract available

  203. YAN M, Yang Y, Zhao Y, Ma L, et al
    Prevalence and genotype distribution of high-risk human papillomavirus infection among Chinese women aged 35-64: A national screening population-based study.
    J Infect. 2026;92:106697.
    PubMed    
    Abstract available

  204. LEONARDSEN AL, Englund E, Trope A, Stensrud M, et al
    The effect of a cervical testing campaign on incarcerated females- a repeated cross-sectional study in Norwegian prisons.
    BMC Womens Health. 2026;26:141.
    PubMed    
    Abstract available

  205. LI P, Wang H
    The diagnostic value of colposcopy in postmenopausal women: a retrospective study.
    BMC Womens Health. 2026;26:140.
    PubMed    
    Abstract available

  206. NAVARRO-TORNE A, Aris E, Callegaro A, Benninghoff B, et al
    Maximizing impact: the power of early HPV vaccination for long-term protection-lessons from a systematic review and meta-regression analysis.
    J Public Health (Oxf). 2026;48:216-227.
    PubMed    
    Abstract available

  207. YIN L, Zhang J, Pang Y, Mou Y, et al
    Predictive value of R2 * values derived from blood oxygen level-dependent magnetic resonance imaging for lymph node metastasis after neoadjuvant chemotherapy for cervical squamous cell carcinoma.
    Clin Radiol. 2026;94:107149.
    PubMed    
    Abstract available

  208. RASHEED A, Shirazi SH, Khan P, Aseere AM, et al
    cervical nuclei segmentation through synergic conditional generative adversarial network in cervical smear images.
    Comput Biol Chem. 2026;122:108918.
    PubMed    
    Abstract available

  209. HE J, Cheng C, Ding Y, Li N, et al
    Design of Therapeutic Vaccines Based on Antigen Epitopes of alpha-9 HPV E6 in Sichuan.
    J Immunother. 2026;49:87-97.
    PubMed    
    Abstract available

  210. LEE YS, Yim K, Kim CJ, Kim JH, et al
    Tumour budding in pretreatment cervical biopsies: a prognosticator for personalised therapy in the era of precision oncology.
    Histopathology. 2026;88:970-984.
    PubMed    
    Abstract available

  211. YASUTAKE N, Yokawa Y, Tanaka T, Mishima R, et al
    Claudin-18 expression in gastric type adenocarcinoma and HPV-associated adenocarcinoma of the uterine cervix.
    Histopathology. 2026;88:1003-1015.
    PubMed    
    Abstract available

  212. AZIM MR, Sakib QN, Rahman MM, Islam MS, et al
    Economic burden of breast, cervical, and oral cancer in Bangladesh: a cost-of-illness study.
    J Cancer Policy. 2026;47:100694.
    PubMed    
    Abstract available

  213. WANG Z, Zhuang L, Liu S, Cao C, et al
    Single-Cell and Multiomic Analysis Reveals Neutrophil Heterogeneity and Prognostic Value in Cervical Lesions.
    Cancer Sci. 2026;117:597-612.
    PubMed    
    Abstract available

  214. GAO T, Farag M, Agha S, Mobula L, et al
    Economic evaluation of the one-dose HPV vaccination program in Nigeria.
    J Cancer Policy. 2026;47:100675.
    PubMed    
    Abstract available

  215. DORJI N, Dorji T, Dorjey Y, Yangdon Y, et al
    Quality improvement initiatives on colposcopy and treatment of cervical pre-cancer services in Bhutan: Experiences, challenges, and way forward.
    J Cancer Policy. 2026;47:100676.
    PubMed    
    Abstract available

  216. NGUYEN-THANH H, Marshall L, Wilson H, Stewart K, et al
    Awareness of HPV-related cancers and the HPV vaccination programme in Scotland: a cross-sectional study of gender, deprivation and knowledge gaps.
    J Public Health (Oxf). 2026;48:239-248.
    PubMed    
    Abstract available

  217. KAYALI E, Comert GK, Yildirim HT, Toptas T, et al
    Nicotinamide Phosphoribosyltransferase (NAMPT) as a New Marker in Cervical Preinvasive Lesions.
    Int J Surg Pathol. 2026;34:385-391.
    PubMed    
    Abstract available

  218. STOUT CE, Poiani LTH, Mcglynn A, Enujioke CDRSC, et al
    Recommendation for Human Papillomavirus Vaccine after Abnormal Pap Smear in Unvaccinated Active Duty Women.
    Mil Med. 2026;191.
    PubMed    
    Abstract available

  219. SAILLANT A, Rasclard M, Gaume JB, Souchaud O, et al
    A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma.
    Anticancer Res. 2023;43:4723-4727.
    PubMed    
    Abstract available

  220. LINDWALL G, Gerlee P
    Bayesian inference on the Allee effect in cancer cell line populations using time-lapse microscopy images.
    J Theor Biol. 2023;574:111624.
    PubMed    
    Abstract available

  221. SAITO M, Rajesh A, Innes C, van der Griend R, et al
    The High-Risk Human Papillomavirus Type Influences the Tissue Microenvironment in Cervical Intraepithelial Neoplasia Grade 2.
    Viruses. 2023;15:1953.
    PubMed    
    Abstract available

  222. CHAIWONGKOT A, Buranapraditkun S, Oranratanaphan S, Chuen-Im T, et al
    Efficiency of CIN2+ Detection by Thyrotropin-Releasing Hormone (TRH) Site-Specific Methylation.
    Viruses. 2023;15:1802.
    PubMed    
    Abstract available

  223. BOUBLENZA L, Nahet A, Masdoua N, Sadouki N, et al
    Prevalence of human papillomavirus infection among women at a gynaecological clinic in Tlemcen, Algeria.
    Afr J Reprod Health. 2023;27:56-63.
    PubMed    
    Abstract available

  224. ZHANG H, Liu C, Zhai X, Zhang Q, et al
    Disfunction of communication among immune cells in minimal-deviation adenocarcinoma of the cervix as an immunotherapeutic opportunity.
    Int Immunopharmacol. 2023;124.
    PubMed    
    Abstract available

  225. HUANG B, Lou Y, Zeng Z, Kan X, et al
    A Cas12a-based fluorescent microfluidic system for rapid on-site human papillomavirus diagnostics.
    Appl Microbiol Biotechnol. 2023;107:6287-6297.
    PubMed    
    Abstract available

  226. KIHARA K, Kajiyama Y, Kimura Y, Okazaki S, et al
    Adult-onset botulism in a Japanese woman with prolonged spore excretion.
    J Infect Chemother. 2023;29:1172-1176.
    PubMed    
    Abstract available

  227. ZHANG C, Li X, Zhong L, Wang Y, et al
    Assessment of the relationships between invasive endocervical adenocarcinoma and human papillomavirus infection and distribution characteristics in China: According to the new WHO classification criteria in 2020.
    Cancer Epidemiol. 2023;86:102442.
    PubMed    
    Abstract available

  228. PAUTIER P, Genestie C, Gladieff L, Kurtz JE, et al
    [Not Available].
    Bull Cancer. 2023;110.
    PubMed    
    Abstract available

  229. WANG X, Shi W, Pu X, Hu Y, et al
    Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:13727-13739.
    PubMed    
    Abstract available

  230. MADZARAC V, Culej D, Muzinic D, Zovko G, et al
    Small-cell neuroendocrine carcinoma of the cervix associated with adenocarcinoma in situ: A case report with analysis of molecular abnormalities.
    Neuro Endocrinol Lett. 2023;44:332-335.
    PubMed    
    Abstract available

  231. VILLANUEVA-AGUILAR ME, Rizo-de la Torre LC, Bencomo-Alvarez AE, Gallegos-Arreola MP, et al
    Sequence analysis of exons 30 and 31 of LAMA3 gene variants and its association with human papillomavirus infection predisposition: no evidence was found.
    Eur Rev Med Pharmacol Sci. 2023;27:6860-6866.
    PubMed    
    Abstract available

  232. ALHARBI SA, Alshammari FD, Humaida MI, Abdalhabib EK, et al
    The cytological pattern of cervical smears of a series of Saudi women in one gynecologic center.
    Eur Rev Med Pharmacol Sci. 2023;27:6785-6791.
    PubMed    
    Abstract available

  233. THANGARAJAH F, Busshoff J, Salamon J, Pruss MS, et al
    Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer.
    J Cancer Res Clin Oncol. 2023;149:12597-12604.
    PubMed    
    Abstract available

  234. ZHAO J, Liu X, Gao J, Xiao H, et al
    Factors Associated with Lesion Recurrence Following Cervical Conization.
    Altern Ther Health Med. 2023;29:50-55.
    PubMed    
    Abstract available

  235. VALENZA C, Spada F, Multinu F, Benini L, et al
    Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
    Endocr Relat Cancer. 2023;30:e230112.
    PubMed    
    Abstract available

  236. BAHARVAND S, Asghari-Jafarabadi M, Nourizadeh R, Sattarzadeh Jahdi N, et al
    The Effect of Decision Aid on Satisfaction With Decision and Anxiety Among Women With Abnormal Cervical Screening Results.
    Cancer Nurs. 2023;46:E405-E411.
    PubMed    
    Abstract available

  237. MARTINS TR, Witkin SS, de Oliveira RL, Gadelha JGS, et al
    EVALUATION AND RECOMMENDATIONS TO MODERNIZE CERVICAL CANCER DETECTION AND PREVENTION PROGRAMS IN BRAZIL: CHALLENGES AND OPPORTUNITIES - A NARRATIVE REVIEW.
    Acta Cytol. 2026 Mar 9:1-20. doi: 10.1159/000550725.
    PubMed    
    Abstract available

  238. HAN K
    Advancing molecular residual disease detection in cervical cancer through next-generation sequencing of circulating human papillomavirus DNA.
    Cancer. 2026;132:e70352.
    PubMed    


  239. BAUDIN L, Zanella L, Lebeau A, Pleyers C, et al
    Non-metastatic para-aortic lymph node remodeling as a predictor of outcome in locally advanced cervical cancer.
    Clin Cancer Res. 2026 Mar 4. doi: 10.1158/1078-0432.CCR-25-3894.
    PubMed    
    Abstract available

  240. SCHEVENHOVEN VJC, Jansen EEL, Siebers AG, de Kok IMCM, et al
    Long-term cervical cancer risk following negative hrHPV-based versus negative cytology-based screening: A population-based study.
    Eur J Cancer. 2026;237:116601.
    PubMed    
    Abstract available

  241. WU SG, Hong SS, Tang YL, Zhou J, et al
    Survival trends among patients with newly diagnosed stage IVB cervical cancer before and after the approval of bevacizumab and immunotherapy.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115045.
    PubMed    
    Abstract available

  242. NAUMANN RW
    Commentary on: Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup Canadian Cancer Trials Group Cx.5/SHAPE tr
    Gynecol Oncol. 2026;205:A1-A2.
    PubMed    


  243. JAIN D, Wahidi M, Effendi J, Hoang L, et al
    Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status.
    Gynecol Oncol. 2026;205:89-98.
    PubMed    
    Abstract available

  244. CUTRI-FRENCH C, Saris DH, Solorzano SS, Wang X, et al
    Disparities in access to gynecologic oncology visits among elderly patients with gynecologic malignancies.
    Gynecol Oncol. 2026;205:63-69.
    PubMed    
    Abstract available

  245. MOREL D, Parvu V, Andrews J, Stephenson P, et al
    HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.
    Gynecol Oncol. 2026;207:40-47.
    PubMed    
    Abstract available

  246. SAAB RH, Salvo G, Gonzales NR, Munsell MF, et al
    Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: A NeCTuR study.
    Gynecol Oncol. 2023;177:95-102.
    PubMed    
    Abstract available

  247. ZHANG Z, Quddus MR, Sung CJ, Singh K, et al
    Morphologic and immunohistochemical study of HPV-related cervical adenosquamous carcinoma: Reappraisal of a poorly defined entity.
    Hum Pathol. 2026;170:106052.
    PubMed    
    Abstract available

  248. NEWTON R, Tenet V, Mugisha J, Kimono B, et al
    Human papillomavirus infection and vaccination among young females in rural Uganda.
    Int J Cancer. 2025 Nov 6. doi: 10.1002/ijc.70227.
    PubMed    
    Abstract available

  249. KARRBERG C, Gray P, Elfgren K, Milerad H, et al
    Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative women.
    Int J Cancer. 2026 Mar 9. doi: 10.1002/ijc.70415.
    PubMed    
    Abstract available

  250. LEHTINEN M, Lipsitch M, Pimenoff VN, Sundstrom K, et al
    Predicting optimal impact interventions in the post-HPV vaccination world.
    Int J Cancer. 2026 Jan 19. doi: 10.1002/ijc.70297.
    PubMed    
    Abstract available

  251. TSEGAYE AT, Mashele SA, Shing JZ, Mwansa-Kambafwile J, et al
    Race-specific temporal trends of HPV-related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011-2022.
    Int J Cancer. 2025 Dec 31. doi: 10.1002/ijc.70323.
    PubMed    
    Abstract available

  252. LEI J, Falcaro M, Brentnall AR, O'Mahony JF, et al
    Indicators to identify cancer screening providers with suboptimal case detection: A scoping review.
    Int J Cancer. 2026;158:2339-2358.
    PubMed    
    Abstract available

  253. ZULFIKAROGLU E
    Cervical cancer screening strategies in women 65 years and older in the human papillomavirus era: A systematic review and meta-analysis of human papillomavirus-based testing and self-sampling approaches.
    Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70962.
    PubMed    
    Abstract available

  254. ZHOU J, Cai J, Li X, Liu C, et al
    Correspondence on "Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study".
    Int J Gynecol Cancer. 2026 Feb 11:104551. doi: 10.1016/j.ijgc.2026.104551.
    PubMed    


  255. SANTIA MC, Morante-Caicedo C, Pineros Castillo WA, Taylor A, et al
    Surgical de-escalation of cervical cancer treatment in limited-resource settings.
    Int J Gynecol Cancer. 2026 Mar 2:102862. doi: 10.1016/j.ijgc.2025.102862.
    PubMed    
    Abstract available

  256. VIVEROS-CARRENO D, Agusti N, Mora-Soto N, Wilke RN, et al
    De-escalation in definitive surgical management for cervical cancer.
    Int J Gynecol Cancer. 2025 Oct 9:102711. doi: 10.1016/j.ijgc.2025.102711.
    PubMed    
    Abstract available

  257. CAICEDO-MARTINEZ M, Arbelaez-Marino AF, Arbelaez L, Farach A, et al
    Refinement in radiotherapy treatment for locally advanced cervical cancer: a historic perspective.
    Int J Gynecol Cancer. 2026 Mar 2:102878. doi: 10.1016/j.ijgc.2025.102878.
    PubMed    
    Abstract available

  258. MORA-SOTO N, Viveros-Carreno D, Morante-Caicedo C, Pineros W, et al
    Neoadjuvant chemotherapy in cervical cancer: a narrative review.
    Int J Gynecol Cancer. 2026 Mar 2:102827. doi: 10.1016/j.ijgc.2025.102827.
    PubMed    
    Abstract available

  259. BROWN MH, Pollock AE, Sun K, Marter K, et al
    Comparing Acute Toxicity of Proton and Photon Radiotherapy in Newly Diagnosed Gynecologic Primaries.
    Int J Radiat Oncol Biol Phys. 2025 Nov 2:S0360-3016(25)06421.
    PubMed    
    Abstract available

  260. MAYBURY EK, Ahmad S, McKenzie ND
    Worldwide Evaluation of Cervical Cancer Self-Sampling Devices.
    Obstet Gynecol. 2026 Feb 26. doi: 10.1097/AOG.0000000000006179.
    PubMed    
    Abstract available

  261. MACKENZIE P, Vajdic C, Delaney G, Comans T, et al
    Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
    Radiother Oncol. 2023;188:109862.
    PubMed    
    Abstract available

  262. BONNAH J, Awuah B, Williams MS
    The role of healthcare providers in shared decision making for cervical cancer prevention in Ghana: A qualitative study.
    BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15785.
    PubMed    


  263. CUI YM, Shan YM, Xiao YY, Gao Y, et al
    Analysis of prognosis in early-stage cervical cancer patients post-conization treated with laparoscopic versus open radical hysterectomy.
    BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15756.
    PubMed    


  264. OUMA GE, Asaso Omwodo K, Itsura P, Poli PA, et al
    Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary center.
    BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15761.
    PubMed    


  265. WU M, Jiang Z, Xian X, Lu M, et al
    Transrectal ultrasound-guided optimization of needle insertion for interstitial brachytherapy in the treatment of vaginal stump recurrence of cervical cancer.
    BMC Cancer. 2026 Mar 7. doi: 10.1186/s12885-026-15819.
    PubMed    


  266. CHEN X, Li J, Sun Y, Ye Z, et al
    LncRNA EGFR-AS1 inhibits ferroptosis to reduce radiosensitivity of cervical cancer through the m6A/IGF2BP3/APAF1 axis.
    BMC Cancer. 2026 Mar 5. doi: 10.1186/s12885-026-15596.
    PubMed    


  267. ABERA GB, Alemayehu M, Sori DA, Ali R, et al
    Time to death and its determinants among cervical cancer patients in Tigray, Ethiopia: a retrospective follow up study.
    BMC Cancer. 2026 Mar 2. doi: 10.1186/s12885-026-15712.
    PubMed    
    Abstract available


  268. Retraction: Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime.
    PLoS One. 2026;21:e0343674.
    PubMed    


  269. ARMIJO N, Espinoza MA, Contreras-Montiel P, Vera M, et al
    Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile.
    PLoS One. 2026;21:e0332010.
    PubMed    
    Abstract available

  270. CUPERTINO BERGOMI L, de Souza Carvalho G, Zanetti de Albuquerque L, Goncalves Kischinhevsky D, et al
    Social inequities and clinical outcomes in young women with cervical cancer: Real-world evidence.
    PLoS One. 2026;21:e0343651.
    PubMed    
    Abstract available

  271. CHEN Y, Qiu W, Xiao G, Zhang R, et al
    Analysis of the correlation between vaginal microbiota and high-risk human papillomavirus infection and cervical lesions.
    PLoS One. 2026;21:e0343027.
    PubMed    
    Abstract available

  272. MITCHELL LE, Phillips E, Jennett CJ, Bavor C, et al
    Experiences of HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervix.
    PLoS One. 2026;21:e0326551.
    PubMed    
    Abstract available

  273. HASBAY E, Sahin S, Kelten Talu EC, Sanci M, et al
    MRI differentiation of usual type endocervical adenocarcinoma and cervical squamous cell carcinoma.
    PLoS One. 2026;21:e0343764.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum


;